-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-28
FITC-Concanavalin A (ConA) Conjugate provides a fluorescent lectin probe for visualizing accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids. It is suited to cell surface carbohydrate detection, immunofluorescence staining, tissue labeling, and flow cytometry, but it should not be treated as a universal glycan marker or used for non-carbohydrate targets.
-
Standardized Whole-Blood Immunometabolism with Etomoxir
2026-08-28
Zhao and colleagues present a standardized fresh whole-blood stimulation protocol that combines defined immune challenges with pharmacological modulation of cellular metabolism. The workflow offers a reproducible way to compare cytokine responses across metabolic conditions and provides a practical framework for fatty acid oxidation pathway research without relying exclusively on purified immune-cell systems.
-
Imatinib (STI571) in NET-Aware CML Research
2026-08-27
Imatinib and STI571 provide a precise way to interrogate Abl, PDGF receptor, and c-Kit signaling in CML models. This article develops a NET-aware assay strategy that separates BCR-ABL1 pathway inhibition from broader neutrophil and tyrosine kinase inhibitor effects.
-
EPI-001: Rethinking AR N-Terminal Inhibition
2026-08-27
EPI-001 offers a mechanistically distinct way to interrogate androgen receptor signaling by targeting the receptor’s N-terminal domain. This thought-leadership article connects CRPC biology with emerging AR/ARv7 evidence in TNBC and provides practical guidance for building translationally credible workflows.
-
CX-5461: From Pol I Stress to Mitotic Failure
2026-08-26
CX-5461 is an RNA polymerase I inhibitor that links ribosome biogenesis stress with DNA damage, senescence, autophagy, and mitotic catastrophe. This article provides a mechanistic framework for selecting assays and interpreting solid-tumor responses beyond a simple viability endpoint.
-
Tobramycin for Reliable Cell Assays
2026-08-26
Learn how Tobramycin (SKU B1856) can be integrated into bacterial, co-culture, and cell-based assay workflows without confusing antimicrobial activity with mammalian cytotoxicity. This scenario-driven guide covers formulation, controls, protocol parameters, data interpretation, and practical reagent selection.
-
Ibuprofen in Cell Viability Assays: A8446 Guide
2026-08-25
Learn how Ibuprofen (SKU A8446) can support reproducible cell viability, proliferation, and cytotoxicity workflows through controlled dosing, solvent matching, and orthogonal readouts. The guide connects COX inhibition and anti-proliferative evidence with practical assay design and vendor-selection criteria.
-
CFDA-SE Workflows for Proliferation and Migration
2026-08-25
CFDA-SE converts intracellular esterase activity into a division-sensitive fluorescence signal for lymphocytes, fibroblasts, NK cells, bacteria, and migration models. This practical guide links staining design, flow cytometry controls, and troubleshooting with the CD38 surfaceome findings from nanobody-targeted TurboID.
-
BHQ: A Translational Lens on SERCA and HSC Mobilization
2026-08-24
A mechanistic and translational analysis of 2,5-di-tert-butylbenzene-1,4-diol (BHQ) as a SERCA perturbation tool, integrating calcium homeostasis, ER stress, vascular physiology, and emerging evidence for hematopoietic stem cell mobilization.
-
Rotenone and the Energy Logic of Autophagy
2026-08-24
Rotenone is a mitochondrial Complex I inhibitor that reveals how bioenergetic stress can reshape apoptosis and autophagy interpretation. This article connects rotenone-based mitochondrial assays with the AMPK–ULK1 energy-stress framework and practical Parkinson’s disease research decisions.
-
Self-Assembling EVMPs for Extrahepatic mRNA Delivery
2026-08-23
The reference study introduces a bottom-up enveloped virus-mimicking particle (EVMP) that combines engineered self-assembling peptides with selected phospholipid envelopes to direct mRNA beyond the liver. Its optimized formulation produced substantial lung-cell transfection and suppressed tumor progression after delivery of IL-12 mRNA, while highlighting a modular strategy for tissue-selective mRNA delivery.
-
ERCC1 Deficiency, p53, and Cisplatin Response
2026-08-22
Heyza and colleagues used CRISPR-Cas9-engineered lung cancer models to show that ERCC1 loss does not produce a uniform platinum response: p53 status strongly influences apoptosis, survival, and interstrand crosslink repair. The study identifies DNA-PKcs and BRCA1 as contributors to cisplatin tolerance in ERCC1-deficient cells, refining how ERCC1 should be interpreted as a biomarker.
-
2X Taq PCR Master Mix for C. elegans Studies
2026-08-22
Build faster C. elegans genotyping, cloning, and sequence-validation workflows with a ready-to-use 2X Taq PCR Master Mix that includes direct-loading dye. Its adenine-overhang chemistry supports TA cloning, while the simplified gel workflow helps connect genetic perturbations to pheromone-driven neurodegeneration experiments.
-
AZD1390: From ATM Inhibition to G4 Stress
2026-08-21
Explore how AZD1390, a selective ATM kinase inhibitor, can sharpen interpretation of radiation and replication-stress assays. This article connects ATM checkpoint signaling with new REV1–DHX36 findings while clearly separating validated evidence from testable hypotheses.
-
Ruxolitinib phosphate: JAK/STAT Assay Workflows
2026-08-20
Build more informative pathway studies with Ruxolitinib phosphate, a selective JAK1/JAK2 tool for cytokine signaling inhibition, inflammatory models, and cancer research. This guide translates recent anaplastic thyroid carcinoma findings into practical assay design, controls, optimization steps, and troubleshooting strategies.